CDKN2A and laryngotracheoesophageal cleft: Estimates of the fraction of cases attributable to HPV based on positivity for HPV-DNA and for either HPV E6*I mRNA or p16INK4a were 22.4%, 4.4%, and 3.5% for OPC, OCC, and LC, respectively [1,11].